BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6146083)

  • 1. Effect of prolyl-leucyl-glycinamide and alpha-melanocyte-stimulating hormone on levorphanol-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Life Sci; 1984 Jun; 34(26):2559-66. PubMed ID: 6146083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effects of prolyl-leucyl-glycinamide on morphine-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Eur J Pharmacol; 1984 Jun; 102(1):13-22. PubMed ID: 6148243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitation of morphine-induced tolerance and physical dependence by prolyl-leucyl-glycinamide.
    Contreras PC; Takemori AE
    Eur J Pharmacol; 1981 May; 71(2-3):259-68. PubMed ID: 6113968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of morphine-induced analgesia, tolerance and dependence by alpha-melanocyte-stimulating hormone.
    Contreras PC; Takemori AE
    J Pharmacol Exp Ther; 1984 Apr; 229(1):21-6. PubMed ID: 6323687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of morphine tolerance and dependence by alpha-melanocyte stimulating hormone(alpha-MSH).
    Székely JI; Miglécz E; Dunai-Kovács Z; Tarnawa I; Rónai AZ; Gráf L; Bajusz S
    Life Sci; 1979 May; 24(21):1931-8. PubMed ID: 37395
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition by L-prolyl-L-leucyl-glycinamide (PLG) of alpha-melanocyte stimulating hormone release from hypothalamic slices.
    Scimonelli T; Celis ME
    Peptides; 1982; 3(6):885-9. PubMed ID: 6132363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The failure of L-prolyl-L-leucylglycinamide to inhibit the release of alpha-melanocyte-stimulating hormone in the rat.
    Thody AJ; Lever de Vries CH; Tilders FJ
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):300-5. PubMed ID: 6103629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensification and attenuation of morphine dependence by D-aspartic acid and PLG.
    Koyuncuoğlu H; Güngör M; Sağduyu H; Aricioğlu F
    Pharmacol Biochem Behav; 1990 Jan; 35(1):47-50. PubMed ID: 1969165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolyl-leucyl-glycinamide (PLG): inhibition of offensive aggression in mice.
    Kavaliers M; Hirst M
    Life Sci; 1986 Nov; 39(19):1729-35. PubMed ID: 2877382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl-leucyl-glycinamide reduces aggression and blocks defeat-induced opioid analgesia in mice.
    Teskey GC; Kavaliers M
    Peptides; 1985; 6(2):165-7. PubMed ID: 2863808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of narcotic tolerance and physical dependence: effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly).
    Bhargava HN; Walter R; Ritzmann RF
    Pharmacol Biochem Behav; 1980 Jan; 12(1):73-7. PubMed ID: 6102769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal fragments of oxytocin (prolyl-leucyl-glycinamide and Z-prolyl-D-leucine) attenuate the development of tolerance to ethanol.
    Szabó G; Kovács GL; Székeli S; Baláspiri L; Telegdy G
    Acta Physiol Hung; 1987; 69(1):115-22. PubMed ID: 2884803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
    Quock RM; Lucas TS; Hartl TJ
    Pharmacol Biochem Behav; 1983 Jul; 19(1):49-52. PubMed ID: 6137836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of morphine analgesia by alpha-MSH, MIF-I, melatonin and naloxone in the rat.
    Datta PC; Sandman CA; Hoehler FK
    Peptides; 1982; 3(3):433-7. PubMed ID: 6126866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory influences of MIF-1 (PLG) and Tyr-MIF-1 (YPLG) on aggression and defeat-induced analgesia in mice.
    Kavaliers M; Hirst M
    Peptides; 1986; 7(6):1007-10. PubMed ID: 2882493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracisternal administration of interleukin-1 beta attenuates naloxone-precipitated withdrawal in morphine-dependent mice.
    Katsumata S; Minami M; Nakagawa T; Satoh M
    Eur J Pharmacol; 1995 May; 278(2):143-50. PubMed ID: 7671998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
    Martin JR; Takemori AE
    J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the oxytocin fragment prolyl-leucyl-glycinamide on sexual behavior in the rat.
    Gorzalka BB; Luck KA; Tanco SA
    Pharmacol Biochem Behav; 1991 Feb; 38(2):273-9. PubMed ID: 1676168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
    Pillai NP; Bhargava HN
    Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
    Chiu S; Mishra RK
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):45-50. PubMed ID: 6111027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.